Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 27% ± 11% | |
lung | 6 studies | 24% ± 6% | |
intestine | 6 studies | 19% ± 7% | |
brain | 6 studies | 26% ± 9% | |
liver | 4 studies | 24% ± 11% | |
bone marrow | 3 studies | 22% ± 6% | |
eye | 3 studies | 20% ± 3% | |
uterus | 3 studies | 28% ± 9% | |
breast | 3 studies | 19% ± 4% | |
lymph node | 3 studies | 23% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 1029.90 | 21 / 21 | 100% | 24.19 | 504 / 504 |
breast | 100% | 1345.54 | 459 / 459 | 100% | 22.71 | 1118 / 1118 |
esophagus | 100% | 922.03 | 1445 / 1445 | 100% | 19.83 | 183 / 183 |
intestine | 100% | 1013.66 | 966 / 966 | 100% | 24.60 | 527 / 527 |
liver | 100% | 520.68 | 226 / 226 | 100% | 12.73 | 406 / 406 |
ovary | 100% | 1426.71 | 180 / 180 | 100% | 24.67 | 430 / 430 |
stomach | 100% | 784.28 | 359 / 359 | 100% | 24.16 | 286 / 286 |
uterus | 100% | 1159.45 | 170 / 170 | 100% | 28.78 | 459 / 459 |
lung | 100% | 976.87 | 577 / 578 | 100% | 24.23 | 1155 / 1155 |
prostate | 100% | 940.71 | 245 / 245 | 100% | 16.61 | 501 / 502 |
brain | 100% | 673.97 | 2634 / 2642 | 100% | 17.58 | 705 / 705 |
thymus | 100% | 1084.14 | 653 / 653 | 100% | 22.41 | 603 / 605 |
pancreas | 100% | 571.80 | 328 / 328 | 99% | 17.01 | 177 / 178 |
adrenal gland | 100% | 785.59 | 258 / 258 | 99% | 17.70 | 228 / 230 |
kidney | 100% | 816.71 | 89 / 89 | 99% | 17.36 | 888 / 901 |
skin | 100% | 1181.13 | 1808 / 1809 | 93% | 17.14 | 440 / 472 |
adipose | 100% | 1311.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.06 | 29 / 29 |
spleen | 100% | 1011.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.95 | 1 / 1 |
blood vessel | 100% | 1019.47 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 892.49 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 671.62 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 743.35 | 814 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 9.50 | 61 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | CCDC59 |
Protein name | Coiled-coil domain containing 59 Thyroid transcription factor 1-associated protein 26 (TTF-1-associated protein 26) (Coiled-coil domain-containing protein 59) (TTF-1-associated protein BR2) |
Synonyms | BR22 HSPC128 TAP26 |
Description | FUNCTION: Component of the transcription complexes of the pulmonary surfactant-associated protein-B (SFTPB) and -C (SFTPC). Enhances homeobox protein Nkx-2.1-activated SFTPB and SFTPC promoter activities. . |
Accessions | F8VNY5 ENST00000256151.8 Q9P031 ENST00000552377.5 |